Almazan J, Turapov T, Kircher D, Stanley K, Culver K, Medellin A
Cell Rep Med. 2025; 6(2):101943.
PMID: 39922199
PMC: 11866499.
DOI: 10.1016/j.xcrm.2025.101943.
Chhibber T, Scherzer M, Prokofyeva A, Becker C, Zitnay R, Smith E
bioRxiv. 2024; .
PMID: 39484595
PMC: 11527197.
DOI: 10.1101/2024.10.17.618694.
Sorino C, Iezzi S, Ciuffreda L, Falcone I
Front Mol Biosci. 2024; 11:1403021.
PMID: 39086722
PMC: 11289331.
DOI: 10.3389/fmolb.2024.1403021.
Battaglia L, Scomparin A, Dianzani C, Milla P, Muntoni E, Arpicco S
Pharmaceutics. 2021; 13(10).
PMID: 34683910
PMC: 8540596.
DOI: 10.3390/pharmaceutics13101617.
Kadrmas J, Beckerle M, Yoshigi M
Sci Rep. 2020; 10(1):19303.
PMID: 33168840
PMC: 7653911.
DOI: 10.1038/s41598-020-75774-3.
BRAF inhibition in melanoma is associated with the dysregulation of histone methylation and histone methyltransferases.
Grigore F, Yang H, Hanson N, VanBrocklin M, Sarver A, Robinson J
Neoplasia. 2020; 22(9):376-389.
PMID: 32629178
PMC: 7338995.
DOI: 10.1016/j.neo.2020.06.006.
Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.
Richards J, Yoo J, Shin D, Odelberg S
Pigment Cell Melanoma Res. 2019; 33(2):264-278.
PMID: 31880399
PMC: 7065156.
DOI: 10.1111/pcmr.12853.
AKT1 Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.
Kircher D, Trombetti K, Silvis M, Parkman G, Fischer G, Angel S
Mol Cancer Res. 2019; 17(9):1787-1800.
PMID: 31138602
PMC: 6726552.
DOI: 10.1158/1541-7786.MCR-18-1372.
The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
Yoo J, Brady S, Acosta-Alvarez L, Rogers A, Peng J, Sorensen L
Cancer Res. 2019; 79(11):2892-2908.
PMID: 31048499
PMC: 7197377.
DOI: 10.1158/0008-5472.CAN-18-3026.
The Power of Fish Models to Elucidate Skin Cancer Pathogenesis and Impact the Discovery of New Therapeutic Opportunities.
Sarasamma S, Lai Y, Liang S, Liu K, Hsiao C
Int J Mol Sci. 2018; 19(12).
PMID: 30544544
PMC: 6321611.
DOI: 10.3390/ijms19123929.
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
Yu Y, Schleich K, Yue B, Ji S, Lohneis P, Kemper K
Cancer Cell. 2018; 33(2):322-336.e8.
PMID: 29438700
PMC: 5977991.
DOI: 10.1016/j.ccell.2018.01.002.
Resistance mechanisms to genetic suppression of mutant NRAS in melanoma.
Robinson J, Rebecca V, Kircher D, Silvis M, Smalley I, Gibney G
Melanoma Res. 2017; 27(6):545-557.
PMID: 29076949
PMC: 5683096.
DOI: 10.1097/CMR.0000000000000403.
Genetically engineered mouse models of melanoma.
Perez-Guijarro E, Day C, Merlino G, Zaidi M
Cancer. 2017; 123(S11):2089-2103.
PMID: 28543694
PMC: 5445933.
DOI: 10.1002/cncr.30684.
Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma.
Yang H, Kircher D, Kim K, Grossmann A, VanBrocklin M, Holmen S
Oncogene. 2017; 36(27):3842-3851.
PMID: 28263969
PMC: 5501768.
DOI: 10.1038/onc.2016.526.
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten;Braf Mice.
Deken M, Song J, Gadiot J, Bins A, Kroon P, Verbrugge I
Int J Mol Sci. 2016; 17(12).
PMID: 27999416
PMC: 5187949.
DOI: 10.3390/ijms17122149.
AKT1 Activation Promotes Development of Melanoma Metastases.
Cho J, Robinson J, Arave R, Burnett W, Kircher D, Chen G
Cell Rep. 2015; 13(5):898-905.
PMID: 26565903
PMC: 4646731.
DOI: 10.1016/j.celrep.2015.09.057.
Current State of Animal (Mouse) Modeling in Melanoma Research.
Kuzu O, Nguyen F, Noory M, Sharma A
Cancer Growth Metastasis. 2015; 8(Suppl 1):81-94.
PMID: 26483610
PMC: 4597587.
DOI: 10.4137/CGM.S21214.
Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.
Burd C, Liu W, Huynh M, Waqas M, Gillahan J, Clark K
Cancer Discov. 2014; 4(12):1418-29.
PMID: 25252692
PMC: 4258185.
DOI: 10.1158/2159-8290.CD-14-0729.
Melanoma: from mutations to medicine.
Tsao H, Chin L, Garraway L, Fisher D
Genes Dev. 2012; 26(11):1131-55.
PMID: 22661227
PMC: 3371404.
DOI: 10.1101/gad.191999.112.
Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma.
McKinney A, Holmen S
Chin J Cancer. 2011; 30(3):153-62.
PMID: 21352692
PMC: 4013311.
DOI: 10.5732/cjc.011.10007.